Engineers Gate Manager LP

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 1620220 NEW YORK, NY

Position in RIGL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$933,637

+$168,730 QoQ

Shares Held

23,866

-15.6% QoQ

Ownership

0.128%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#67

of 156 holders

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $195,993,154 across 162 Biotechnology names. RIGL ranks #56 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$933,637	23,866	-15.6%	Shares	Sole	2026-08-14
2026-03-31	$764,907	28,288	+55.2%	Shares	Sole	2026-05-15
2025-12-31	$780,876	18,232	-30.1%	Shares	Sole	2026-02-17
2025-09-30	$738,421	26,065	+106.7%	Shares	Sole	2025-11-14
2024-12-31	$212,083	12,609	+24.1%	Shares	Sole	2025-02-14
2024-03-31	$15,039	10,162	0.0%	Shares	Sole	2024-05-15
2023-12-31	$14,734	10,162	0.0%	Shares	Sole	2024-02-14
2023-09-30	$10,974	10,162	-1.0%	Shares	Sole	2023-11-14
2023-06-30	$13,237	10,262	0.0%	Shares	Sole	2023-08-14
2023-03-31	$13,545	10,262	+1.0%	Shares	Sole	2023-05-15
2022-12-31	$15,243	10,162	-70.6%	Shares	Sole	2023-02-14
2022-03-31	$103,211	34,519	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.